HIGH-VOLUME · BLOOD GLUCOSE INCREASED
exenatide Side Effects
exenatide (also sold as Byetta, Bydureon) is HIGH-VOLUME in this FAERS book #137 of 524 by FAERS report count. Signature opener: BLOOD GLUCOSE INCREASED - BLOOD GLUCOSE INCREASED leads at 15,472 reports (29.6% of the book).
Data updated 2026-05-15
- 52,302
- FAERS reports
FAERS voluntary reports, 2005 to 2025. High volume tracks exposure and reporting culture; see methodology for de-dup rules.
Among 52,302 FAERS reports for exenatide, BLOOD GLUCOSE INCREASED is the most-reported reaction (15,472). Volume band HIGH-VOLUME #137 of 524 by FAERS report count.
High-report extract for exenatide (Byetta): 52,302 FAERS rows (2005-2025). Top named reactions: BLOOD GLUCOSE INCREASED, WEIGHT DECREASED, NAUSEA. Outcome stamps DEATH-MARKED · HOSP-MID · SEX-BALANCED. FAERS is voluntary signal detection, not incidence.
Counts from the openFDA FAERS extract (2005–2025). Stamps CASELOAD · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
BLOOD GLUCOSE INCREASED leads 15,472 of 52,302 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (20,550 reports)
Reporting taper since 2005 peak
Reactions in Death Reports
Death appears on 1,762 reports (3.4% - MARKED). Reactions below co-occur in those rows only.
| Reaction | Reports |
|---|---|
| PANCREATIC CARCINOMA | 765 |
| DEATH | 346 |
| PANCREATIC CARCINOMA METASTATIC | 268 |
| METASTASES TO LIVER | 178 |
| RENAL FAILURE | 94 |
| PANCREATITIS | 91 |
| ADENOCARCINOMA PANCREAS | 90 |
| NAUSEA | 82 |
| WEIGHT DECREASED | 77 |
| HYPERTENSION | 74 |
| JAUNDICE CHOLESTATIC | 65 |
| METASTASES TO LUNG | 64 |
| MYOCARDIAL INFARCTION | 60 |
| PANCREATITIS ACUTE | 60 |
| VOMITING | 58 |
| ASCITES | 53 |
| ACUTE KIDNEY INJURY | 52 |
| METASTASES TO LYMPH NODES | 51 |
| CHOLELITHIASIS | 45 |
| BLADDER CANCER | 44 |
Reactions in Hospitalization Reports
Hospitalization mid-share (7,532, 14.4%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| WEIGHT DECREASED | 1,332 |
| NAUSEA | 1,199 |
| BLOOD GLUCOSE INCREASED | 1,150 |
| PANCREATITIS | 1,033 |
| VOMITING | 813 |
| PANCREATITIS ACUTE | 574 |
| DIARRHOEA | 483 |
| DECREASED APPETITE | 481 |
| BLOOD GLUCOSE DECREASED | 431 |
| DEHYDRATION | 377 |
| RENAL FAILURE | 360 |
| DIZZINESS | 333 |
| FALL | 331 |
| ABDOMINAL PAIN | 329 |
| DYSPNOEA | 325 |
| RENAL FAILURE ACUTE | 306 |
| ASTHENIA | 296 |
| MYOCARDIAL INFARCTION | 272 |
| MALAISE | 271 |
How to read exenatide FAERS figures (CASELOAD · DEATH-MARKED · HOSP-MID)
FAERS holds 52,302 voluntary reports linked to exenatide (Byetta, Bydureon), 2005-2025. Death is listed on 1,762 (3.4%). Hospitalization appears on 7,532 (14.4%). Top co-reported indication: Type 2 Diabetes Mellitus.
CASELOAD books overweight common drugs and loud reporting cultures; BLOOD GLUCOSE INCREASED is the page opener, not a per-patient risk.
Read with exenatide
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-MARKED · HOSP-MID stamps.
ABS(total_reports) peer at 51,859 FAERS cases (Δ 443 lighter vs exenatide); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 51,370 FAERS cases (Δ 932 lighter vs exenatide); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 53,266 FAERS cases (Δ 964 heavier vs exenatide); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 50,521 FAERS cases (Δ 1,781 lighter vs exenatide); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's CASELOAD · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 58.7 pp vs exenatide's DEATH-MARKED): CASELOAD · HOSP-MID.
exenatide sits in CASELOAD; high report volume tracks exposure and reporting culture more than per-patient risk. Methodology states the de-dup rules.